Predictive and Prognostic Value of BRAF and NRAS Mutation of 159 Sentinel Lymph Node Cases in Melanoma—A Retrospective Single-Institute Study

por Liszkay, Gabriella, Mátrai, Zoltán, Czirbesz, Kata, Jani, Nóra, Bencze, Eszter, Kenessey, István
Publicado 2021

Immune cell profile of sentinel lymph nodes in patients with malignant melanoma – FOXP3(+) cell density in cases with positive sentinel node status is associated with unfavorable c...

por Mohos, Anita, Sebestyén, Tímea, Liszkay, Gabriella, Plótár, Vanda, Horváth, Szabolcs, Gaudi, István, Ladányi, Andrea
Publicado 2013

Atezolizumab for the treatment of advanced recurrent basal cell carcinoma and urothelial carcinoma of bladder: a case report

por Küronya, Zsófia, Danyi, Tímea, Balatoni, Tímea, Liszkay, Gabriella, Tóth, Erika, Biró, Krisztina, Géczi, Lajos
Publicado 2022

HLA Class I Downregulation in Progressing Metastases of Melanoma Patients Treated With Ipilimumab

por Ladányi, Andrea, Hegyi, Barbara, Balatoni, Tímea, Liszkay, Gabriella, Rohregger, Raphael, Waldnig, Christoph, Dudás, József, Ferrone, Soldano
Publicado 2022

The Role of Stereotactic Radiotherapy in the Management of Melanoma, A Retrospective Single Institute Preliminary Study of 30 Patients

por Kispál, Mihály, Jánváry, Levente Zsolt, Balatoni, Tímea, Gábor, Stelczer, Fedorcsák, Imre, Katalin, Bőcs, Kenessey, István, Liszkay, Gabriella
Publicado 2022

Role of the anatomic site in the association of HLA class I antigen expression level in metastases with clinical response to ipilimumab therapy in patients with melanoma

por Ladányi, Andrea, Papp, Eszter, Mohos, Anita, Balatoni, Tímea, Liszkay, Gabriella, Oláh, Judit, Varga, Anita, Lengyel, Zsuzsanna, Emri, Gabriella, Ferrone, Soldano
Publicado 2020

Therapeutic and Adverse Effect of Anti-PD1 Immunotherapy in Melanoma: A Retrospective, Single-Institute Study of 222 Patients

por Eikenes, Grethe, Liszkay, Gabriella, Balatoni, Tímea, Czirbesz, Kata, Hunyadi, Karen, Kozéki, Zsófia, Kispál, Mihály Tamás, Baranyai, Fanni, Danyi, Tímea, Bőcs, Katalin, Kenessey, István
Publicado 2023

Anti-tumor antibody profile analysis to harness the potentials of B cells in melanomas and the natural humoral immune response

por Kotlan, Beatrix, Liszkay, Gabriella, Blank, Miri, Olasz, Judit, Csuka, Orsolya, Balatoni, Timea, Borbola, Kinga, Toth, Laszlo, Naszados, Gyorgy, Marincola, Francesco M, Godeny, Maria, Kasler, Miklos, Shoenfeld, Yehuda
Publicado 2013

Epileptic Seizure Provoked by Bone Metastasis of Chronic Lymphoid Leukemia and Merkel Cell Carcinoma

por Folyovich, András, Majoros, Angéla, Jarecsny, Tamás, Pánczél, Gitta, Pápai, Zsuzsanna, Rudas, Gábor, Kozák, Lajos, Barna, Gábor, Béres-Molnár, Katalin A., Vadasdi, Károly, Liszkay, Gabriella, Horváth, Eszter, Toldi, Gergely
Publicado 2020

Revealing cancer initiating cells in metastatic melanomas by harnessing the host′s anti tumor humoral immune mechanisms

por Kotlan, Beatrix, Liszkay, Gabriella, Naszados, Gyorgy, Olasz, Judit, Horvath, Szabolcs, Eles, Klara, Blank, Miri, Shoenfeld, Yehuda, Gobor, Laszlo, Toth, Laszlo, Csuka, Orsolya, Godeny, Maria, Kasler, Miklos, Marincola, Francesco M
Publicado 2014

New strategy to reveal the black seeds of melanomas (cancer stem cells) with their vulnerable characteristics at cellular and molecular levels

por Kotlan, Beatrix, Liszkay, Gabriella, Naszados, Gyorgy, Dolescall, Zoltan, Toth, Laszlo, Gobor, Laszlo, Vamosy, Istvan N, Szollar, Andras, Horvath, Szabolcs, Eles, Klara, Csuka, Orsolya, Kasler, Miklos, Godeny, Maria, Marincola, Francesco M
Publicado 2013

Minor tumor infiltrating B cells opened a door to reveal and eliminate cancer initiating cells in metastatic melanomas

por Kotlan, Beatrix, Liszkay, Gabriella, Naszados, Gyorgy, Olasz, Judit, Horvath, Szabolcs, Plotar, Vanda, Szollar, Andras, Vamosi, Istvan Nagy, Savolt, Akos, Toth, Laszlo, Csuka, Orsolya, Godeny, Maria, Kasler, Miklos, Marincola, Francesco M
Publicado 2014

“Immune B Cells know it better”: tumorimmunological panel assay to define tumor-associated antigen binding antibodies in patients with metastatic melanomas

por Kotlan, Beatrix, Balatoni, Timea, Csirbesz, Katalin, Olasz, Judit, Csuka, Orsolya, Toth, Laszlo, Farkas, Emil, Savolt, Akos, Szollar, Andras, Ujhelyi, Mihaly, Horvath, Szabolcs, Eles, Klara, Kasler, Miklos, Marincola, Francesco M, Liszkay, Gabriella
Publicado 2015

Challenging tumour immunological techniques that help to track cancer stem cells in malignant melanomas and other solid tumours

por Kotlan, Beatrix, Plotar, Vanda, Eles, Klara, Horvath, Szabolcs, Balatoni, Timea, Csuka, Orsolya, Újhelyi, Mihaly, Sávolt, Ákos, Szollar, Andras, Vamosi-Nagy, Istvan, Toth, Laszlo, Farkas, Emil, Toth, Jozsef, Kasler, Miklos, Liszkay, Gabriella
Publicado 2018

Tumor-Associated Disialylated Glycosphingolipid Antigen-Revealing Antibodies Found in Melanoma Patients' Immunoglobulin Repertoire Suggest a Two-Direction Regulation Mechanism Betw...

por Kotlan, Beatrix, Horvath, Szabolcs, Eles, Klara, Plotar, Vanda K., Naszados, Gyorgy, Czirbesz, Katalin, Blank, Miri, Farkas, Emil, Toth, Laszlo, Tovari, Jozsef, Szekacs, Andras, Shoenfeld, Yehuda, Godeny, Maria, Kasler, Miklos, Liszkay, Gabriella
Publicado 2019

Contribution of MEK Inhibition to BRAF/MEK Inhibitor Combination Treatment of BRAF-Mutant Melanoma: Part 2 of the Randomized, Open-Label, Phase III COLUMBUS Trial

por Ascierto, Paolo A., Dummer, Reinhard, Gogas, Helen J., Arance, Ana, Mandala, Mario, Liszkay, Gabriella, Garbe, Claus, Schadendorf, Dirk, Krajsova, Ivana, Gutzmer, Ralf, Chiarion-Sileni, Vanna, Dutriaux, Caroline, de Groot, Jan Willem B., Yamazaki, Naoya, Loquai, Carmen, Robert, Caroline, Flaherty, Keith T.
Publicado 2023

coBRIM: a phase 3, double-blind, placebo-controlled study of vemurafenib versus vemurafenib + cobimetinib in previously untreated BRAF(V600) mutation–positive patients with unresec...

por Ascierto, Paolo A, McArthur, Grant A, Dréno, Brigitte, Larkin, James, Liszkay, Gabriella, Maio, Michele, Mandala, Mario, Demidov, Lev, Stroyakovskiy, Daniil, Thomas, Luc, de la Cruz-Merino, Luis, Atkinson, Victoria, Dutriaux, Caroline, Garbe, Claus, Chang, Ilsung, Hack, Stephen P, Ribas, Antoni
Publicado 2015

Changing Trends in Melanoma Incidence and Decreasing Melanoma Mortality in Hungary Between 2011 and 2019: A Nationwide Epidemiological Study

por Liszkay, Gabriella, Kiss, Zoltan, Gyulai, Roland, Oláh, Judit, Holló, Péter, Emri, Gabriella, Csejtei, András, Kenessey, István, Benedek, Angela, Polányi, Zoltán, Nagy-Erdei, Zsófia, Daniel, Andrea, Knollmajer, Kata, Várnai, Máté, Vokó, Zoltán, Nagy, Balázs, Rokszin, György, Fábián, Ibolya, Barcza, Zsófia, Polgár, Csaba
Publicado 2021

Improving Quality Indicator of Melanoma Management – Change of Melanoma Mortality-to-Incidence Rate Ratio Based on a Hungarian Nationwide Retrospective Study

por Várnai, Máté, Kiss, Zoltán, Gyulai, Rolland, Oláh, Judit, Holló, Péter, Emri, Gabriella, Csejtei, András, Kenessey, István, Benedek, Angéla, Polányi, Zoltán, Nagy-Erdei, Zsófia, Dániel, Andrea, Knollmajer, Kata, Rokszin, György, Fábián, Ibolya, Barcza, Zsófia, Polgár, Csaba, Nagy, Balázs, Liszkay, Gabriella, Vokó, Zoltán
Publicado 2021

COLUMBUS 5-Year Update: A Randomized, Open-Label, Phase III Trial of Encorafenib Plus Binimetinib Versus Vemurafenib or Encorafenib in Patients With BRAF V600–Mutant Melanoma

por Dummer, Reinhard, Flaherty, Keith T., Robert, Caroline, Arance, Ana, de Groot, Jan Willem B., Garbe, Claus, Gogas, Helen J., Gutzmer, Ralf, Krajsová, Ivana, Liszkay, Gabriella, Loquai, Carmen, Mandalà, Mario, Schadendorf, Dirk, Yamazaki, Naoya, di Pietro, Alessandra, Cantey-Kiser, Jean, Edwards, Michelle, Ascierto, Paolo A.
Publicado 2022